Semaglutide is well-tolerated in the GLP-1 receptor agonist class, with the most common side effects being mild nausea and appetite reduction during the first 1-2 weeks
no video visit unless clinically necessary Initial review typically completed within 2448 hours after intake Treatments Offered Weekly GLP-1 injections: Ozempic, Wegovy, Mounjaro, Zepbound, compounded semaglutide, and compounded liraglutide Daily (once or twice) oral weight-loss medications: bupropion, metformin, topiramate, B12, naltrexone App-based sleep, nutrition, and exercise guidance: included Additional services : birth control, ED treatment, skincare, mental health Bottom Line Hims and Hers is a solid option for adults who want GLP-1 access through a trusted, gender-specific telehealth brand
That is relatively low
Results may vary depending on factors such as age, baseline hormone levels, amino acid availability, and overall health